TRP_1170x120_3-8-19

Indianapolis insulin manufacturing facility

Eli Lilly earmarks funds for insulin facility upgrade

Eli Lilly earmarks funds for insulin facility upgrade

INDIANAPOLIS — Eli Lilly and Co. plans to invest $72 million in an insulin manufacturing project at one of its Indianapolis facilities. Eli Lilly said the investment will be used to replace a current insulin vial-filling line. The move also stands to enable the company to meet rising demand for its insulins — including Humalog